Life SciencesHematologyImmunologyClinical ImmunologyImmunopathologyAntibody CharacterizationAntibody FunctionAutoantibodiesAutoimmune Hematologic DiseasePlatelet DisordersPlatelet PhysiologyAutoimmune ThrombocytopeniaImmune-mediated Thrombocytopenia
Ten patients with idiopathic thrombocytopenic purpura (ITP) were studied before and following a rise in circulating platelets subsequent to infusions of intravenous gammaglobulin (400 mg/kg/day x 5 days). We quantitated the amount of circulating IgG capable of binding to normal donor platelets in vitro using an 125I-monoclonal anti-human IgG assay, as well as the amount of IgG associated with the patients' platelets before and following therapy. We found no evidence for a decrease in platelet-specific IgG antibodies in these patients undergoing an acute response to therapy. These data suggest that the short-term efficacy of intravenous gammaglobulin is due to effects other than a substantive reduction in platelet reactive antibodies, such as the alteration of IgG-coated platelet destruction.
13
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura
JB Bussel, RD Inman, I Schulman et al. · Blood · 1983 · 299 citations · Full text
Modulation of mononuclear phagocyte function by intravenous gamma-globulin.
Robert P. Kimberly, Jane E. Salmon, J B Bussel et al. · The Journal of Immunology · 1984 · 190 citations
Immune Thrombocytopenic Purpura
Albert F. LoBuglio, Wayne S. Court, Leigh Vinocur et al. · New England Journal of Medicine · 1983 · 98 citations